PolyPeptide Group
11 May 2021

Proclamation honoring Jane Salik upon her retirement

The city of Torrance, California, honored Jane Salik for her investment in the Torrance community and her outstanding contributions to the Science and Peptide Industry. 05-11-21 […]
29 April 2021
PolyPeptide_SIX_listing

Stock Exchange Listing

What an exhilarating day! Today the PolyPeptide Group became a public company. Our shares began trading on SIX, the Swiss Stock Exchange. Our entire Executive Committee was […]
28 January 2021

PolyPeptide News Flash, #1, 2021

PolyPeptide Group maintained a strong and healthy pipeline that has gained a significant growth in 2020. This growth in Pipeline Projects reflects the growth in peptide […]
28 January 2021

Therapeutic Indications for the PolyPeptide Group Pipeline Projects 2020

PolyPeptide Group maintained a strong and healthy pipeline that has gained a significant growth in 2020. This growth in Pipeline Projects reflects the growth in peptide […]
8 December 2020
Pic graphic

New In-Silico Development Tools Support More Efficient Process Design

Advanced Peptide Synthesis Program Uses Predictive Modeling and Simulation Tools to Shorten Peptide Process Development The field of Solid Phase Peptide Synthesis (SPPS) has boomed over […]
17 September 2020
SPPS 600L reactor

PolyPeptide News Flash, #3, 2020

As a Global Leader in Peptide Manufacturing and Development, the PolyPeptide Group has been actively engaged on projects with clients who are developing peptide-based therapies and […]
17 September 2020
Polypeptide screen

Capacity Expansion through Investment and Innovation

Considering the continuous growth and evolution of the Peptide therapeutic market, the strategy of the PolyPeptide Group is to anticipate the market needs and to extend […]
4 June 2020
Press Release

Press Release: PolyPeptide Group Selected by Novavax to Manufacture Critical Intermediates of Matrix-M™ Adjuvant for its COVID-19 Vaccine

The PolyPeptide Group, a global Contract Development and Manufacturing Organization (CDMO) for Peptide, Peptidomimetic and other Drug Substances, has announced that it has partnered with Novavax […]
12 May 2020
covid-19

PolyPeptide News Flash, #2, 2020

While the COVID-19 crisis continues, the PolyPeptide Group is actively engaged in helping find treatments and vaccines for COVID-19. See report on promising therapies in our […]